⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MLTX News
MoonLake Immunotherapeutics Class A Ordinary Shares
MLTX ALERT: Securities Fraud Class Action Launched Against MoonLake Immunotherapeutics - December 15, 2025 Deadline
accessnewswire.com
MLTX
MLTX SHAREHOLDER ALERT: MoonLake Immunotherapeutics Investors are Encouraged to Act before the Upcoming December 15 Deadline - Contact BFA Law if You Lost Money
accessnewswire.com
MLTX
Your Guide to the MoonLake Immunotherapeutics Lawsuit - A SueWallSt Podcast From Levi & Korsinsky
accessnewswire.com
MLTX
Pomerantz LLP Advises Shareholders of Class Action Involving MoonLake Immunotherapeutics – MLTX
accessnewswire.com
MLTX
Securities Fraud Class Action Filed Against MoonLake Immunotherapeutics (MLTX) - Levi & Korsinsky Reminds Investors of December 15, 2025
accessnewswire.com
MLTX
Pomerantz LLP Advises Shareholders of Class Action Filing Involving MoonLake Immunotherapeutics – MLTX
accessnewswire.com
MLTX
Shareholders of MoonLake Immunotherapeutics (MLTX): Protect Your Rights Before December 15, 2025 - Contact Levi & Korsinsky
accessnewswire.com
MLTX
Pomerantz LLP Advises Shareholders of Class Action Filing Against MoonLake Immunotherapeutics – MLTX
accessnewswire.com
MLTX
December 15, 2025 Deadline: Join Class Action Lawsuit Against MoonLake Immunotherapeutics (MLTX) - Contact Levi & Korsinsky
accessnewswire.com
MLTX
Pomerantz LLP Advises Shareholders of Class Action Against MoonLake Immunotherapeutics – MLTX
accessnewswire.com
MLTX